Financial statements Biogliko
Balance sheet data of BIOGLIKO
|
Year
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|
| Total assets | 649 010,37 | 146 460,95 | 92 042,38 | 49 129,91 |
| A. Fixed assets | 157 637,83 | 113 645,71 | 69 653,59 | 25 792,47 |
| B. Current assets | 491 372,54 | 32 815,24 | 22 388,79 | 23 337,44 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 649 010,37 | 146 460,95 | 92 042,38 | 49 129,91 |
| A. Equity | 268 625,91 | 122 681,37 | 51 118,21 | -13 761,93 |
| B. Liabilities and provisions for liabilities | 380 384,46 | 23 779,58 | 40 924,17 | 62 891,84 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 4 504,39 | 23 390,28 | 40 924,17 | 62 891,84 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.